Does Oxcarbazepine Cause Memory Loss?
Oxcarbazepine does not typically cause memory loss as a primary adverse effect, though it can cause cognitive impairment in other domains, particularly difficulty with concentration, psychomotor slowing, and speech/language problems. 1
Evidence from FDA Drug Labeling
The FDA-approved labeling for oxcarbazepine clearly identifies cognitive adverse reactions but does not list memory loss as a prominent feature. The cognitive symptoms are categorized into three main types 1:
- Cognitive symptoms: psychomotor slowing, difficulty with concentration, and speech or language problems
- Somnolence or fatigue
- Coordination abnormalities: ataxia and gait disturbances
In clinical trials, 7.1% of oxcarbazepine-treated adults experienced cognitive adverse reactions versus 4% on placebo 1. Notably, the specific cognitive complaint was "concentration impairment" rather than memory deficits.
Clinical Trial Evidence
Adult Studies
The American Academy of Neurology/American Epilepsy Society guidelines from 2004 reviewed class I evidence for oxcarbazepine in refractory epilepsy 2. The most frequent adverse events identified were:
- Somnolence
- Dizziness
- Headache
- Ataxia
- Nausea
- Vomiting
Memory loss was not listed among the adverse events in these large-scale trials, which included 694 patients 2.
Pediatric Studies
In children aged 3-17 years, cognitive adverse events occurred in 5.8% of oxcarbazepine-treated patients, with the single most common event being concentration impairment (4 of 138 patients), not memory problems 1. The most common adverse events in children were somnolence, headache, dizziness, vomiting, and nausea 2.
Comparative Cognitive Studies
A 2006 study directly comparing oxcarbazepine to topiramate found that oxcarbazepine actually improved delayed word recall performance compared to topiramate, which showed worse working memory and verbal fluency 3. This suggests oxcarbazepine may have a relatively favorable cognitive profile regarding memory.
Another 2006 study in children and adolescents found no differences in cognitive tests between oxcarbazepine and carbamazepine/valproate over 6 months 4.
Most compellingly, a 1993 study in healthy volunteers found that oxcarbazepine had no effect on long-term memory processes and actually improved some aspects of psychomotor functioning 5.
Clinical Implications
If a patient on oxcarbazepine reports memory problems, consider:
- Alternative causes: Epilepsy itself causes memory impairment independent of medication
- Concentration deficits masquerading as memory problems: Difficulty concentrating (which oxcarbazepine does cause) can present as apparent memory issues
- Polytherapy effects: Combined antiepileptic drugs increase cognitive side effects
- Dose-related effects: Higher doses (especially 2,400 mg/day) increase cognitive adverse events
Important Caveats
The cognitive effects are dose-dependent and more pronounced with polytherapy. In the pivotal trial, 65% of patients discontinued at 2,400 mg/day when added to existing antiepileptic drugs due to primarily CNS-related adverse events 1. However, in monotherapy trials at the same dose, discontinuation rates for cognitive adverse events were minimal 1.
Bottom line: Oxcarbazepine causes concentration difficulties and psychomotor slowing, not memory loss per se. If memory complaints arise, investigate other causes before attributing them to oxcarbazepine.